Type One Ventures
22619 Pacific Coast Highway B350, Malibu, CA, 90265-5036, United States
Overview
Type One Ventures invests in early-stage startups developing technology, infrastructure, and services. Type One Ventures empowers the entrepreneurs providing the technology, infrastructure, and services that will be integral to the growth and advancement of mankind.
- Total investments
- 17
- Lead investments
- 4
- Investments · 12mo
- 5
- Active investors
- 4
Sector focus
- Aerospace
- Artificial Intelligence (AI)
- Financial Services
- FinTech
- Robotics
- Software
- Space Travel
Investment portfolio
- Lunar Outpost
Participated · Series B · May 2026
Lunar Outpost builds and deploys scalable rover systems and autonomous coordination software for operations in GPS-denied and extreme space environments. The company has developed multiple generations of its Mobile Autonomous Prospecting Platform (MAPP) and is advancing next-generation lunar terrain vehicles tied to NASA’s LTVS program. It is also developing the STRATFI-supported MARS platform to enable resilient multi-vehicle autonomy across lunar, orbital, and terrestrial applications. The company reports flight heritage for several rover classes and plans to lead eight missions launching to the Moon before 2030. Financially, Lunar Outpost recently raised an oversubscribed $30 million Series B to accelerate production, expand manufacturing capacity, and deploy mission-ready systems for Artemis and national security customers.
- BioOrbit
Participated · Seed · Apr 2026
BioOrbit develops compact, modular autonomous manufacturing units called BOX to perform crystallisation of biological drugs in microgravity at industry-relevant scale. The company positions BOX as a microwave-sized payload that moves crystallisation from one-off experiments to repeatable manufacturing pathways not achievable on Earth. BioOrbit says its technology enables better-performing biologics and is engaging with the NHS and the UK Space Agency while working on regulatory pathways with the MHRA, Regulatory Innovation Office and CAA. The company was founded and funded by Dr. Katie King and co-founder oncology researcher Dr. Leonor Teles and has appointed senior pharma-and-space executives to its leadership team. BioOrbit has participated in accelerators including Airbus Accelerator, Seraphim Space Accelerator, ESA BSGN Life Sciences, ESA BIC UK and the UK Space Agency LEO Accelerator. The articles do not disclose current revenue or user metrics.
- Axiom Space
Led · Equity · Feb 2026
Axiom Space is building commercial orbital infrastructure, with headline programs that include a commercial space station and development of lunar spacesuits for NASA’s Artemis lunar exploration campaign. The company is pursuing a broader roadmap of space infrastructure and technology advancement and has positioned itself to define the next era of the space economy. Financially, Axiom recently closed an expanded funding round that grew to more than $525 million after an opportunistic extension that brought in new and existing investors. The company said the funds will be used to support its space station and spacesuit efforts as well as other roadmap priorities. Axiom has publicly welcomed NASA’s decision to continue the Commercial LEO Destinations program under its established approach, which it says aligns with its commercial station plans.
- Natilus
Participated · Series A · Feb 2026
Founded in 2016, San Diego-based Natilus is engineering a family of blended-wing-body (BWB) aircraft that reduce fuel consumption by 30 %, cut carbon emissions and operating costs by 50 %, and boost payload capacity by 40 %. Its first product, the KONA regional freighter, carries a 3.8-ton payload and is designed for both commercial freight and defense logistics, with a first full-scale flight targeted within 24 months. The company is concurrently developing the 200-plus-seat HORIZON EVO passenger jet, aimed at the Boeing 737 MAX and Airbus A321neo market and slated for entry into service in the early 2030s. Natilus has secured more than 570 aircraft pre-orders worth an estimated $24 billion from customers such as SpiceJet, Nolinor Aviation, Flexport and Ameriflight. The firm is pursuing FAA Part 23, Amendment 64 certification for KONA and evaluating a 250,000 sq ft factory capable of producing 60 units per year. By using existing engine technology and airport infrastructure, Natilus seeks to de-risk adoption and accelerate commercialization. The team includes alumni from Boeing, Northrop Grumman, Skunk Works, SpaceX and other leading aerospace organizations.
- PsiQuantum
Participated · Series E · Sep 2025
Founded in 2016, PsiQuantum develops photonic quantum computers and fabricates its chips with GlobalFoundries in New York. The company pursues a photonics-based architecture intended to address scalability for industrial-scale quantum machines. PsiQuantum has stated a goal of operating its first commercial‑scale machine around 2030. Financially, it raised $1.0 billion at a $7.0 billion valuation in a round led by BlackRock, Temasek and Baillie Gifford, with participation from Nvidia’s venture arm, and it has secured multiple government engagements including DARPA awards and potential CHIPS support. Recent corporate changes include naming Victor Peng as permanent CEO and adding Intel CEO Lip‑Bu Tan to the board, alongside new hires from Sandisk and Synopsys. The company’s near-term roadmap and technology will be externally evaluated under DARPA’s program, which aims to determine viability toward a 2033 industrial-scale target.